A randomized, open-label, two-cycle, two-crossover phase I clinical trial comparing the bioequivalence and safety of afatinib and Giotrif(®) in healthy Chinese subjects
一项随机、开放标签、两周期、两交叉的 I 期临床试验,旨在比较阿法替尼和吉奥替利嗪®在健康中国受试者中的生物等效性和安全性。
期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-022-04148-1
Liu, Guangwen; Xue, Jinling; Wang, Yanli; Liu, Zhengzhi; Li, Xue; Qu, Dongmei; Su, Zhengjie; Xu, Kaibo; Qu, Xinyao; Qu, Zhaojuan; Sun, Linlin; Cao, Mingming; Wang, Ying; Chen, Xuesong; Yu, Jing; Liu, Lang; Deng, Qiaohuan; Zhao, Yicheng; Zhang, Lixiu; Yang, Haimiao